Where does IFGCure Holdings, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), IFGCure Holdings, LLC ranks #16,096 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does IFGCure Holdings, LLC hold?

IFGCure Holdings, LLC holds 18 US utility patents granted between 2019 and 2024, spanning 8 technology areas.

What is IFGCure Holdings, LLC's Innovation Score?

IFGCure Holdings, LLC has an Innovation Score of 25.1 out of 100 (16th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is IFGCure Holdings, LLC's patent grant rate increasing or decreasing?

IFGCure Holdings, LLC's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for IFGCure Holdings, LLC's patents?

IFGCure Holdings, LLC's patents average 6.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the IFGCure Holdings, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

IFGCure Holdings, LLC

Q: What technology areas does IFGCure Holdings, LLC focus on?

IFGCure Holdings, LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 7 patents, ranking #891 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 18 granted patents across 8 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ifgcure ranks #16,096 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 8 technology areas.

#16,096
of 49,997 US assignees by volume: 16th percentile
by Innovation Score (25.1/100): 6.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16096 · US Corporation #16,096 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,096/49,997
PHOTO-FINISH Hydragraphix
CPC-NARROW A61F · 8 areas
INNOV-THIN 25.1/100
CLAIMS-SPARSE 6.0 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hydragraphix LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ifgcure’s 25.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (41%) Velocity 1.3 pts (5%) Breadth 10.0 pts (40%) Claim depth 3.6 pts (14%)

Qualcomm Incorporated · highest

85
IFGCure Holdings · this assignee

25
3D Lighting… · lowest

7

What this shows Ifgcure's Innovation Score is 25.1/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ifgcure?

Each dot is one of Ifgcure’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ifgcure’s own 6.0 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ifgcure vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ifgcure's grants concentrate

IFGCure Holdings, LLC is a focused PatentsView assignee: 8 CPC subclasses with 38.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (9 grants) versus a trough of 1 in 2024. By volume, Ifgcure sits between Hydragraphix LLC and Inolex Investment Corporation.

Ifgcure's three-year grant acceleration

IFGCure Holdings, LLC shows 3 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hydragraphix

18
Icl-ip America

18
Idhl Holdings

18
IDT Europe

18
Includefitness

18
Indian Institute…

18
Innoscience (Suzh…

18
Inolex Investment

18
Ifgcure Holdings ◀

18

What this shows IFGCure holds 18 patents at rank #16,094, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near IFGCure

By rank, the assignees closest to #16,094 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in IFGCure's primary technology class.

Ifgcure's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

IFGCure Holdings, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	9	50.0%
2020	3	16.7%
2021	3	16.7%
2022	2	11.1%
2024	1	5.6%

Which technologies does IFGCure Holdings, LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

A41B - SHIRTS; UNDERWEAR; Baby LINEN; Handkerchiefs 7

A41C - CORSETS; Brassieres 6

A41D - OUTERWEAR; Protective GARMENTS; Accessories 3

A41F - Garment FASTENINGS; Suspenders 2

A41H - Appliances OR Methods FOR Making Clothes, e.g. FOR Dress-making OR FOR Tailoring, NOT Otherwise Provided FOR 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

IFGCure Holdings, LLC's patent record in context - here's where to go next.

IFGCure Holdings, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 38.9% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #16,096 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare IFGCure Holdings, LLC against Hydragraphix LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.